D. Joshua

International uniform response criteria for multiple myeloma

Brian G.M. Durie, J-L Harousseau, Jesús F. San Miguel et al. · Leukemia · 2006 · 2.6K citations

Medicine, Hematology, Oncology +12

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)

Sergio Giralt, Edward A. Stadtmauer, Jean‐Luc Harousseau et al. · Leukemia · 2009 · 230 citations

Medicine, Hematology, Oncology +17

Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade

Hayley Suen, Ross Brown, S Samuel Yang et al. · Leukemia · 2016 · 192 citations

Life Sciences, Immunology, Oncology +17

Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance

Christian Bryant, Hayley Suen, Ross Brown et al. · Blood Cancer Journal · 2013 · 135 citations · Full text

Life Sciences, Hematology, Immunology +17

Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study

Philippe Moreau, D. Joshua, W-J Chng et al. · Leukemia · 2016 · 78 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15